rs11946396

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001083619.3(GRIA2):​c.229+18344A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.409 in 151,932 control chromosomes in the GnomAD database, including 14,802 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 14802 hom., cov: 32)

Consequence

GRIA2
NM_001083619.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.00

Publications

2 publications found
Variant links:
Genes affected
GRIA2 (HGNC:4572): (glutamate ionotropic receptor AMPA type subunit 2) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene. [provided by RefSeq, Jul 2008]
GRIA2 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language impairment and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.664 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIA2NM_001083619.3 linkc.229+18344A>G intron_variant Intron 2 of 15 ENST00000264426.14 NP_001077088.2 P42262-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIA2ENST00000264426.14 linkc.229+18344A>G intron_variant Intron 2 of 15 1 NM_001083619.3 ENSP00000264426.9 P42262-1

Frequencies

GnomAD3 genomes
AF:
0.409
AC:
62016
AN:
151812
Hom.:
14759
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.670
Gnomad AMI
AF:
0.353
Gnomad AMR
AF:
0.292
Gnomad ASJ
AF:
0.297
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.270
Gnomad FIN
AF:
0.342
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.379
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.409
AC:
62119
AN:
151932
Hom.:
14802
Cov.:
32
AF XY:
0.405
AC XY:
30050
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.670
AC:
27770
AN:
41438
American (AMR)
AF:
0.291
AC:
4440
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.297
AC:
1029
AN:
3470
East Asian (EAS)
AF:
0.175
AC:
904
AN:
5164
South Asian (SAS)
AF:
0.271
AC:
1305
AN:
4816
European-Finnish (FIN)
AF:
0.342
AC:
3609
AN:
10548
Middle Eastern (MID)
AF:
0.401
AC:
117
AN:
292
European-Non Finnish (NFE)
AF:
0.321
AC:
21825
AN:
67942
Other (OTH)
AF:
0.379
AC:
799
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1684
3369
5053
6738
8422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.376
Hom.:
1813
Bravo
AF:
0.417
Asia WGS
AF:
0.283
AC:
982
AN:
3470

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.10
DANN
Benign
0.36
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11946396; hg19: chr4-158161303; API